STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
You’re reading our ESMO in 30 Seconds newsletter. Sign up here to get updates from future major European cancer conferences in your inbox. We’ve made it. Here’s our last newsletter from this year’s European Society for Medical Oncology meeting. But…
ImpactNotable 34/100
Why it mattersnimble: medium (p 0.71)
RegionsGlobal
Published10 h ago (Mon, 26 Oct 2026 23:17:13 GMT)
RetrievedTue, 27 Oct 2026 00:00:31 GMT via rss
ClassifiedTue, 27 Oct 2026 00:36:16 GMT by nimble
AuthorAdam Feuerstein and Andrew Joseph